Gad Getz

119PUBLICATIONS
1086CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (119)

|Jun 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|Jun 03, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|Apr 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

|Apr 08, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Omar Nadeem, Michelle P Aranha, Robert A Redd

|Mar 30, 2026
Mutant ribosomal protein RPS15 drives B cell malignancy through oxidative stress and genomic instability.

Catherine Gutierrez, Marwan Kwok, Neil Ruthen

|Mar 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

D Bennett, M Wierdl, S Chakraborty

Pageof 20

Frequent Collaborators

19 joint publications

Catherine J Wu

19 joint publications

Donna S Neuberg

18 joint publications

Irene M Ghobrial

17 joint publications

Ignaty Leshchiner